NPI: 1407191216 · PHOENIX, AZ 85012 · Multi-Specialty Clinic/Center · NPI assigned 12/05/2012
Authorized official BIRDI, SHIVA controls 19+ related entities in our dataset. Read more
| Authorized Official | BIRDI, SHIVA (CEO) |
| Parent Organization | BANNER MEDICAL GROUP |
| NPI Enumeration Date | 12/05/2012 |
Other providers sharing the same authorized official: BIRDI, SHIVA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 59,070 | $3.33M |
| 2019 | 64,842 | $3.21M |
| 2020 | 77,601 | $3.13M |
| 2021 | 93,500 | $4.62M |
| 2022 | 100,645 | $5.54M |
| 2023 | 118,080 | $5.47M |
| 2024 | 87,633 | $4.39M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 90,875 | 84,309 | $7.58M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 107,709 | 101,797 | $6.29M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 86,943 | 85,228 | $3.84M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 38,517 | 36,501 | $3.29M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 33,206 | 32,739 | $3.03M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 21,713 | 21,547 | $1.98M |
| 90461 | 29,434 | 28,020 | $1.08M | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 8,018 | 7,971 | $798K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 17,378 | 16,801 | $324K |
| 99381 | 2,927 | 2,875 | $283K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 7,482 | 7,149 | $278K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 12,595 | 12,104 | $209K |
| 87428 | 2,904 | 2,825 | $184K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 6,274 | 6,024 | $179K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2,951 | 2,931 | $74K |
| 92551 | 10,889 | 10,344 | $61K | |
| 99383 | 506 | 502 | $53K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,309 | 968 | $24K |
| 99173 | 12,423 | 11,812 | $19K | |
| 90474 | 1,058 | 990 | $18K | |
| 0071A | 190 | 177 | $15K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 392 | 387 | $14K |
| 0072A | 153 | 139 | $12K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 75 | 72 | $9K |
| 99174 | 1,601 | 1,589 | $9K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 94 | 91 | $7K |
| 99382 | 56 | 56 | $6K | |
| 99443 | 63 | 59 | $5K | |
| 94760 | 3,082 | 2,727 | $3K | |
| 99215 | Prolong outpt/office vis | 27 | 27 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 168 | 149 | $3K |
| 90473 | 115 | 113 | $2K | |
| 96161 | 698 | 655 | $2K | |
| 94664 | 109 | 107 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 62 | 54 | $2K |
| 90670 | 13,818 | 12,575 | $2K | |
| 90671 | 1,050 | 1,021 | $1K | |
| 81003 | 701 | 653 | $1K | |
| 87807 | 75 | 75 | $997.22 | |
| 96380 | 44 | 44 | $775.36 | |
| 90686 | 19,602 | 17,877 | $723.37 | |
| 90480 | 27 | 27 | $696.52 | |
| 99051 | 53 | 44 | $664.84 | |
| 87420 | 33 | 33 | $461.20 | |
| 96127 | 93 | 91 | $443.72 | |
| 85018 | 163 | 159 | $439.17 | |
| 90698 | 10,989 | 10,088 | $335.89 | |
| 99441 | 31 | 29 | $281.50 | |
| 99177 | 53 | 53 | $243.19 | |
| 90621 | 51 | 51 | $239.51 | |
| 90680 | 7,829 | 7,209 | $143.69 | |
| 90677 | 357 | 297 | $139.13 | |
| 99000 | 39 | 37 | $100.34 | |
| 90633 | 4,389 | 4,075 | $98.53 | |
| 90656 | 712 | 512 | $94.76 | |
| 90696 | 493 | 470 | $93.93 | |
| 90651 | 938 | 898 | $67.88 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 32 | 28 | $63.55 |
| 90744 | 4,235 | 3,941 | $39.56 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 123 | 115 | $19.32 |
| 90700 | 884 | 843 | $16.97 | |
| 99499 | 1,824 | 1,756 | $12.71 | |
| 90674 | 243 | 235 | $11.42 | |
| 94761 | 13 | 12 | $10.89 | |
| 1160F | 4,874 | 4,508 | $2.82 | |
| 1159F | 5,040 | 4,641 | $2.48 | |
| 1111F | 4,189 | 3,851 | $2.22 | |
| 4040F | 2,982 | 2,788 | $1.09 | |
| 3074F | 2,213 | 2,162 | $0.78 | |
| 3078F | 2,009 | 1,962 | $0.72 | |
| G9921 | No screening performed, partial screening performed or positive screen without recommendations and reason is not given or otherwise specified | 37 | 36 | $0.04 |
| 4037F | 94 | 92 | $0.02 | |
| 90697 | 611 | 556 | $0.00 | |
| 90716 | 2,071 | 1,957 | $0.00 | |
| 91307 | 63 | 61 | $0.00 | |
| 90619 | 109 | 102 | $0.00 | |
| 90707 | 2,067 | 1,950 | $0.00 | |
| 90734 | 479 | 434 | $0.00 | |
| 90710 | 520 | 489 | $0.00 | |
| 90685 | 1,399 | 1,147 | $0.00 | |
| 90648 | 949 | 907 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 548 | 523 | $0.00 |
| 90715 | 212 | 195 | $0.00 | |
| 90713 | 15 | 15 | $0.00 |